Cargando…

No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials

Purpose/objective: Adjuvant radiotherapy after breast conserving surgery is the standard approach in early stage breast cancer. However, the extent of breast tissue that has to be targeted with radiation has not been determined yet. Traditionally, the whole breast was covered by two opposing tangent...

Descripción completa

Detalles Bibliográficos
Autores principales: Haussmann, Jan, Budach, Wilfried, Corradini, Stefanie, Krug, David, Tamaskovics, Balint, Bölke, Edwin, Djiepmo-Njanang, Freddy-Joel, Simiantonakis, Ioannis, Kammers, Kai, Matuschek, Christiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464494/
https://www.ncbi.nlm.nih.gov/pubmed/32824414
http://dx.doi.org/10.3390/cancers12082309
_version_ 1783577378491990016
author Haussmann, Jan
Budach, Wilfried
Corradini, Stefanie
Krug, David
Tamaskovics, Balint
Bölke, Edwin
Djiepmo-Njanang, Freddy-Joel
Simiantonakis, Ioannis
Kammers, Kai
Matuschek, Christiane
author_facet Haussmann, Jan
Budach, Wilfried
Corradini, Stefanie
Krug, David
Tamaskovics, Balint
Bölke, Edwin
Djiepmo-Njanang, Freddy-Joel
Simiantonakis, Ioannis
Kammers, Kai
Matuschek, Christiane
author_sort Haussmann, Jan
collection PubMed
description Purpose/objective: Adjuvant radiotherapy after breast conserving surgery is the standard approach in early stage breast cancer. However, the extent of breast tissue that has to be targeted with radiation has not been determined yet. Traditionally, the whole breast was covered by two opposing tangential beams. Several randomized trials have tested partial breast irradiation (PBI) compared to whole breast irradiation (WBI) using different radiation techniques. There is evidence from randomized trials that PBI might result in lower mortality rates compared to WBI. We aimed to reassess this question using current data from randomized trials. Material/methods: We performed a systematic literature review searching for randomized trials comparing WBI and PBI in early stage breast cancer with publication dates after 2009. The meta-analysis was performed using the published event rates and the effect sizes for overall survival (OS), breast cancer-specific survival (BCSS), and non-breast cancer death (NBCD) as investigated endpoints. Analysis of subgroups using different radiation techniques was intended. We used hazard ratios (HR) and risk differences (RD) to estimate pooled effect sizes. Statistical analysis was performed using the inverse variance heterogeneity model. Results: We identified eleven studies randomizing between PBI and WBI. We did not find significant differences in OS (n = 14,070; HR = 1.02; CI-95%: 0.89–1.16; p = 0.810, and n = 15,203; RD = −0.001; CI-95%: −0.008–0.006; p = 0.785) and BCSS (n = 15,203; RD = 0.001; CI-95%: −0.002–0.005; p = 0.463). PBI also did not result in a significant decrease of NBCD (n = 15,203; RD = −0.003; CI-95%: −0.010–0.003; p = 0.349). A subgroup analysis by radiation technique also did not point to any detectable differences. Conclusion: In contrast to a previous assessment of mortality, we could not find a detrimental effect of WBI on OS or NBCD. A longer follow-up might be necessary to fully assess the long-term mortality effects of PBI compared to WBI.
format Online
Article
Text
id pubmed-7464494
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74644942020-09-04 No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials Haussmann, Jan Budach, Wilfried Corradini, Stefanie Krug, David Tamaskovics, Balint Bölke, Edwin Djiepmo-Njanang, Freddy-Joel Simiantonakis, Ioannis Kammers, Kai Matuschek, Christiane Cancers (Basel) Article Purpose/objective: Adjuvant radiotherapy after breast conserving surgery is the standard approach in early stage breast cancer. However, the extent of breast tissue that has to be targeted with radiation has not been determined yet. Traditionally, the whole breast was covered by two opposing tangential beams. Several randomized trials have tested partial breast irradiation (PBI) compared to whole breast irradiation (WBI) using different radiation techniques. There is evidence from randomized trials that PBI might result in lower mortality rates compared to WBI. We aimed to reassess this question using current data from randomized trials. Material/methods: We performed a systematic literature review searching for randomized trials comparing WBI and PBI in early stage breast cancer with publication dates after 2009. The meta-analysis was performed using the published event rates and the effect sizes for overall survival (OS), breast cancer-specific survival (BCSS), and non-breast cancer death (NBCD) as investigated endpoints. Analysis of subgroups using different radiation techniques was intended. We used hazard ratios (HR) and risk differences (RD) to estimate pooled effect sizes. Statistical analysis was performed using the inverse variance heterogeneity model. Results: We identified eleven studies randomizing between PBI and WBI. We did not find significant differences in OS (n = 14,070; HR = 1.02; CI-95%: 0.89–1.16; p = 0.810, and n = 15,203; RD = −0.001; CI-95%: −0.008–0.006; p = 0.785) and BCSS (n = 15,203; RD = 0.001; CI-95%: −0.002–0.005; p = 0.463). PBI also did not result in a significant decrease of NBCD (n = 15,203; RD = −0.003; CI-95%: −0.010–0.003; p = 0.349). A subgroup analysis by radiation technique also did not point to any detectable differences. Conclusion: In contrast to a previous assessment of mortality, we could not find a detrimental effect of WBI on OS or NBCD. A longer follow-up might be necessary to fully assess the long-term mortality effects of PBI compared to WBI. MDPI 2020-08-17 /pmc/articles/PMC7464494/ /pubmed/32824414 http://dx.doi.org/10.3390/cancers12082309 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Haussmann, Jan
Budach, Wilfried
Corradini, Stefanie
Krug, David
Tamaskovics, Balint
Bölke, Edwin
Djiepmo-Njanang, Freddy-Joel
Simiantonakis, Ioannis
Kammers, Kai
Matuschek, Christiane
No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials
title No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials
title_full No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials
title_fullStr No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials
title_full_unstemmed No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials
title_short No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials
title_sort no difference in overall survival and non-breast cancer deaths after partial breast radiotherapy compared to whole breast radiotherapy—a meta-analysis of randomized trials
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464494/
https://www.ncbi.nlm.nih.gov/pubmed/32824414
http://dx.doi.org/10.3390/cancers12082309
work_keys_str_mv AT haussmannjan nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials
AT budachwilfried nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials
AT corradinistefanie nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials
AT krugdavid nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials
AT tamaskovicsbalint nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials
AT bolkeedwin nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials
AT djiepmonjanangfreddyjoel nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials
AT simiantonakisioannis nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials
AT kammerskai nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials
AT matuschekchristiane nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials